Silo Pharma, Inc. (SILO) Insider Trading Activity

NASDAQ$1.3299+0.05 (3.91%)
Market Cap
$1.44M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
363 of 849
Rank in Industry
212 of 491

SILO Insider Trading Activity

SILO Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$7,657
5
100
Sells
$0
0
0

Related Transactions

Weisblum EricChief Executive Officer
5
$7,657
0
$0
$7,657

About Silo Pharma, Inc.

Silo Pharma Inc. operates as a developmental-stage biopharmaceutical firm dedicated to creating treatments for a variety of underserviced medical conditions. These include stress-related psychiatric disorders, persistent pain syndromes, and diseases impacting the central nervous system (CNS). The company's approach combines both traditional and psychedelic therapies, with a strong emphasis on innovative formulations and advanced drug delivery systems. Leading its pipeline is SPC-15, an intranasal treatment engineered to address post-traumatic …

Insider Activity of Silo Pharma, Inc.

Over the last 12 months, insiders at Silo Pharma, Inc. have bought $7,657 and sold $0 worth of Silo Pharma, Inc. stock.

On average, over the past 5 years, insiders at Silo Pharma, Inc. have bought $14,152 and sold $0 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Weisblum Eric (Chief Executive Officer) — $7,657.

The last purchase of 5,000 shares for transaction amount of $2,075 was made by Weisblum Eric (Chief Executive Officer) on 2025‑12‑15.

List of Insider Buy and Sell Transactions, Silo Pharma, Inc.

2025-12-15PurchaseWeisblum EricChief Executive Officer
5,000
0.0647%
$0.41
$2,075
-14.40%
2025-11-21PurchaseWeisblum EricChief Executive Officer
1,000
0.0118%
$0.36
$365
-10.26%
2025-11-20PurchaseWeisblum EricChief Executive Officer
1,000
0.0128%
$0.37
$370
-3.39%
2025-11-19PurchaseWeisblum EricChief Executive Officer
4,500
0.058%
$0.41
$1,823
-10.96%
2025-11-18PurchaseWeisblum EricChief Executive Officer
7,500
0.0924%
$0.40
$3,025
-15.82%
2025-05-27PurchaseWeisblum EricChief Executive Officer
10,000
0.135%
$0.43
$4,329
+3.14%
2024-12-13PurchaseWeisblum EricCEO and President
2,500
0.0557%
$0.84
$2,097
-17.16%
2024-11-22PurchaseWeisblum EricCEO and President
2,500
0.0502%
$0.90
$2,250
-13.80%
2024-11-20PurchaseWeisblum EricCEO and President
2,500
0.053%
$0.95
$2,375
-21.12%
2024-06-12PurchaseWeisblum EricCEO and President
4,438
0.1099%
$1.11
$4,926
-0.90%
2024-06-11PurchaseWeisblum EricCEO and President
562
0.0135%
$1.08
$607
-2.65%
2024-04-05PurchaseWeisblum EricCEO and President
400
0.0181%
$2.03
$812
-39.02%
2024-04-04PurchaseWeisblum EricCEO and President
600
0.0262%
$1.96
$1,176
-36.55%
2024-04-01PurchaseWeisblum EricCEO and President
1,100
0.0469%
$1.91
$2,101
-32.63%
2024-03-28PurchaseWeisblum EricCEO and President
3,408
0.1474%
$1.94
$6,612
-34.36%
2023-12-20PurchaseWeisblum EricCEO and President
200
0.0072%
$1.61
$322
-8.39%
2023-12-19PurchaseWeisblum EricCEO and President
500
0.0182%
$1.63
$815
-10.94%
2023-12-15PurchaseWeisblum EricCEO and President
900
0.0305%
$1.52
$1,368
-4.64%
2023-12-14PurchaseWeisblum EricCEO and President
200
0.0067%
$1.50
$300
-4.00%
2023-12-07PurchaseWeisblum EricCEO and President
324
0.0098%
$1.36
$441
-2.03%
Total: 43
*Gray background shows transactions not older than one year

Insider Historical Profitability

<0.0001%
Weisblum EricChief Executive Officer
216932
19.2212%
$277,672.96420
<0.0001%
Ryweck Daniel E.Chief Financial Officer
5000
0.443%
$6,400.0010
<0.0001%
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$6,974,678
45
-14.98%
$4.63M
$633,070
27
-5.89%
$2.04M
$8,249,886
17
-47.87%
$399,787.00
$117,515
16
-27.38%
$1.66M
$1,246,170
12
65.67%
$5.42M

SILO Institutional Investors: Active Positions

Increased Positions9+60%737,221+47.53%
Decreased Positions6-40%1M-69.28%
New Positions4New423,660New
Sold Out Positions3Sold Out982,282Sold Out
Total Postitions18+20%1M-21.75%

SILO Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Anson Funds Management Lp$320.007.33%952,381+952,381New2025-09-30
Advisorshares Investments Llc$123.002.81%364,878+180,642+98.05%2025-09-30
Virtu Financial Llc$36.000.83%107,786+107,786New2025-09-30
Geode Capital Management, Llc$13.000.31%39,596+289+0.73%2025-09-30
Jane Street Group, Llc$6.000.13%16,772+16,772New2025-09-30
Two Sigma Securities, Llc$6.000.13%16,471-26,748-61.89%2025-09-30
Vanguard Group Inc$5.000.13%16,33400%2025-09-30
Stonex Group Inc.$5.000.1%13,430+13,430New2025-09-30
State Street Corp$4.000.1%12,50000%2025-09-30
Ubs Group Ag$3.000.07%8,984+8,984New2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

No data is available at this moment.
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.